MDSCs are associated with inflammation-induced tumor progression, as they are activated by pro-inflammatory IL-1β that subsequently induces a tumor-promoting IL-10-dominated environment and an anti-inflammatory (M2) macrophage response (175, 176). Here, IL10 is linked to neoplasm.